Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept

ClinicalTrials.gov ID: NCT00384423

Public ClinicalTrials.gov record NCT00384423. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 7:38 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Phase IIa Study to Assess the Short-Term Effects of PRX-03140 Alone and in Combination With Donepezil in Subjects With Mild Alzheimer's Disease.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PRX-03140 administered orally once daily for 14 days in subjects with mild Alzheimer's Disease who are using a stable, well-tolerated 10 mg dose of Aricept (donepezil) but continue to experience worsening AD symptoms.

Study identification

NCT ID
NCT00384423
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Epix Pharmaceuticals, Inc.
Industry
Enrollment
80 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
60 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2006 (Type not available)
Primary completion
Oct 2007 (Actual)
Completion
Not listed
Last update posted
Jan 30, 2008

Started 2006

United States locations

U.S. sites
17
U.S. states
10
U.S. cities
16
Facility City State ZIP Site status
California Clinical Trials Medical Group, Inc Paramount California 90723 —
Southwest CLinical Research Rancho Mirage California 94109 —
Pacific Research Network, Inc San Diego California 92103 —
San Francisco Clinical Research Center San Francisco California 94109 —
Torrance Clinical Research Torrance California 90505 —
Research Center for Clinical Studies Darien Connecticut 06820 —
Miami Jewish Home and Hospital for the Aged Miami Florida 33137 —
Berma Research Plantation Florida 33317 —
Comprehensive NeuroScience, Inc St. Petersburg Florida 33702 —
Meridien Research St. Petersburg Florida 33709 —
Atlanta Center for Medical Research Atlanta Georgia 30308 —
J. Gary Booker, MD Shreveport Louisiana 71104 —
Neuroscience Research of the Berkshires Pittsfield Massachusetts 01201 —
Neurology Specialists Dayton Ohio 45408 —
Saint Johns Office Building Tulsa Oklahoma 74104 —
The Clinical Trial Center, LLC Jenkintown Pennsylvania 19046 —
Alliance for Neuro Research, LLC Greenville South Carolina 29615 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00384423, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 30, 2008 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00384423 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →